News and Conferences

CoreRx® > Resources > News and Conferences

Latest News

Our latest news and updates, and see where to learn more about CoreRx at Conferences, Trade Shows and Events

NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering

October 11, 2022

Read more

CoreRx Appoints Dan Dobry as Chief Strategy Officer

July 24, 2022

Read more
CoreRx Announces Successful US FDA Inspection of Clearwater Facility

CoreRx Invests in Drug Development and Manufacturing Technologies and Capabilities

June 27, 2022

Read more
CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.

CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.

June 1, 2022

Read more
CoreRx Announces Additions to Senior Scientific Staff

CoreRx Announces Additions to Senior Scientific Staff

April 8, 2022

Read more
An Interview with... Ajay Damani - CEO, CoreRx

An Interview with… Ajay Damani – CEO, CoreRx

December 10, 2021

Read more
CoreRx Announces Successful US FDA Inspection of Clearwater Facility

CoreRx Announces Successful US FDA Inspection of Clearwater Facility

November 22, 2021

Read more
CoreRx Announces New Leadership of Commercial Team

CoreRx Announces New Leadership of Commercial Team

August 2, 2021

Read more
CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

July 1, 2021

Read more
CoreRx Acquires Nucleo Life Sciences

CoreRx Acquires Nucleo Life Sciences

May 24, 2021

Read more
CoreRx Inc. receives approval for Schedule I controlled drug manufacture

CoreRx Inc. receives approval for Schedule I controlled drug manufacture

April 30, 2021

Read more
CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

August 3, 2020

Read more
CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.

CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.

March 25, 2020

Read more
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development

JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development

February 4, 2020

Read more
Load more

Upcoming Conferences

CPhI North America

April 25-27
Philadelphia, PA

Booth#1205

Contract Pharma 2023

September 21-22, 2023
New Brunswick, NJ

Booth TBD

AAPS 2023
PharmSci 360

October 22-25
Orlando, FL

Booth #2323

Focused on Your Success

At CoreRx, we pride ourselves on continuous communication and partner engagement, innovative formulation and manufacturing solutions, and focus and dedication to meeting your drug program expectations.  Tell us about your program, and we’ll tell you how we can help you succeed!

Contact us